Julia Pitcher/LinkedIn
Nov 14, 2026, 23:32
Julia Pitcher: Strengthening Legislative Efforts for the Sickle Cell and Thalassemia Community
Julia Pitcher, Associate Director of State Government Affairs at Agios Pharmaceuticals, shared a post on LinkedIn:
“Great day in Brooklyn with, Teresa Ginger Davis, the force behind the Sickle Cell and Thalassemia Patient Network of NY for their legislative breakfast with my colleague Gar Horton from Agios Pharmaceuticals who presented on how hemolysis causes life-threatening organ damage in both children and adults living with SCD.
Really looking forward to working with this group in the next year continuing the legislative work at the State House for the patient community!”
Stay updated with Hemostasis Today.
-
Nov 14, 2026, 23:33Alexandros Makis: Exploring Vascular Mechanisms and Therapeutic Targets in β-Thalassemia
-
Nov 14, 2026, 23:32Kalyan Roy: Asundexian Approval Marks a Milestone in Targeted Anticoagulation
-
Nov 14, 2026, 23:31Sidi Mohamed El Amine Benlazar: The Role of Cytoreductive Therapy in MPN-Associated Splanchnic Vein Thrombosis
-
Nov 14, 2026, 23:24Roxana González: Pathogenesis of Vascular Disease in Behcet’s Syndrome
-
Nov 14, 2026, 23:15Pierre Sabouret: Despite the NEJM Publication, I Still Prefer DOACs
-
Nov 14, 2026, 16:35Sultan Aydın Aslantaş: A Rare Coexistence of LAHPS and Bloom Syndrome in a Child
-
Nov 14, 2026, 16:27Nicolas Moniotte: Dual-Platform Gene Editing for Haemophilia A
-
Nov 14, 2026, 15:30Patient Selection for Gene Therapy in Transfusion-Dependent β-Thalassemia – EHA
-
Nov 14, 2026, 15:07Vaidehi Prasanth: Patient Blood Management in Hematological Patients A New Book Chapter